9-valent HPV L1 protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58) · HPV
Health Canada DIN 02437058. Check the product and formulation on your record before using a schedule.
Plan doses for this product →This vaccine helps protect against nine types of human papillomavirus (HPV) that can cause certain cancers and genital warts.
GARDASIL 9 is listed under Health Canada DIN 02437058. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
02437058Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.
The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.
The practical points are adapted from the Pharmasist reference for GARDASIL 9 and its matching product monograph.
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
One dose of 9-valent HPV vaccine for people who start at age 9 through 20.
Age at the first dose decides the schedule. A 2-dose schedule may be considered on an individual basis. People who are immunocompromised or living with HIV need three doses.
Optional two-dose schedule, at least 24 weeks apart.
May be considered individually for people who start at age 9 through 20, after discussion with a healthcare provider. The two doses must be at least 24 weeks apart.
Two doses of 9-valent HPV vaccine at least 24 weeks apart.
Recommended for people 21 through 26 years of age: two doses at least 24 weeks (6 months) apart.
Two doses at least 24 weeks apart, decided with a healthcare provider.
At 27 years and older, HPV vaccination is a shared decision with a healthcare provider (GARDASIL 9 is authorized to 45 years). When given: two doses at least 24 weeks apart.
Three doses of 9-valent HPV vaccine at months 0, 2 and 6.
For people 9 years and older who are immunocompromised or living with HIV, regardless of age. Minimum intervals: 4 weeks between doses 1 and 2, 12 weeks between doses 2 and 3, and 24 weeks between doses 1 and 3.
Family guidance on pregnancy: Can be offered in pregnancy; it is usually deferred until after, and a dose given before pregnancy was known is not a concern.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.
Explore care options